People are at the heart of everything we do, and Prime people make our business uniquely successful.
We are thrilled to announce the arrival of Gordon Muir-Jones to our team. Gordon is both highly regarded and experienced, having been directly involved in the development and implementation of multiple global and domestic medical communications projects for over 30 years.
read more >>
We are thrilled to announce the acquisition of Aventine Consulting LLC.
Aventine Consulting LLC, founded by Holly Trautman and Jamie Dunning in 2008, is a US-based consulting firm specialising in US-focused market access and payer communications.
Joining forces with Aventine will enable Prime to offer a full spectrum of health economics, market access, value communications and evidence services. Importantly, providing a local US presence to geographically support US-based global clients and meet the increasing needs of the US domestic market.
read more >>
We’d like to give a very warm welcome to our latest IGNITE cohort. Having begun on 31st October with an introductory session, we hope our latest IGNITEES find the programme insightful and enjoyable!
read more >>
In recognition of both Health Literacy Month and Breast Cancer Awareness Month, we’re looking at the unmet treatment education needs of people living with breast cancer who experience low health literacy.
October is World Breast Cancer Awareness Month, and 13 October is Metastatic Breast Cancer Awareness Day. Let’s look at how the views of people living with metastatic breast cancer provide a vital, underestimated component of assessing the benefits of novel treatments.
Melissa Purves is a Scientific Team Lead at Prime Global. Here she talks about the variety in her role, the people she works with, and how rewarding she finds being a line manager!
read more >>
Prime Global, a recognised global leader in medical communications, evidence and access, and patient engagement, has acquired earthware, an award-winning creative digital agency that creates life-changing solutions to real world healthcare problems. earthware joins Prime Global in supporting pharma and biotech clients at every step of the healthcare journey; their industry-leading technology expertise will complement Prime Global’s scientific heritage and proven delivery, enhancing and expanding Prime Global’s existing digital capabilities.
read more >>
An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community support.
Have hybrid congresses reached their full potential in providing a true omnichannel experience? Michelle Collins, Head of Digital Solutions at Prime Global, discusses.
The working day accounts for a lot of our time. On average, over a third of people’s days are spent at work. Because of this, it is extremely important we ensure we are spending this time in a place that is enjoyable and rewarding to work at.
read more >>
We are delighted to have been featured in MM+M’s article, A medical marketing blind spot: LGBTQIA+ communities being left behind.
read more >>
Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.
We take a look at the value of patient data, how it can impact Pharma and to what extent it could benefit the industry.
We caught up with Senior Health Economist Idaira Rodriguez Santana, to find out more about her role as well as her biggest achievements so far!
read more >>
For Pride Month 2022, Prime Patient investigate how Pharma can build stronger, more productive relationships with the LGBTQIA+ community
This Pride Month, Prime Patient takes a close look at the health inequity faced by the transgender community, and what we can do about it.
A very warm welcome to the latest cohort of our entry-level training programme, IGNITE. This marks the seventh round since the programme’s inception in 2017, and features trainees across our Medical Communications and Evidence, Access, and Patient practice areas.
read more >>
This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.
On May 24th, the Prime Patient team was fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration.
Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.
Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.
Prime Patient collaborate with award-winning advocate Trishna Bharadia to explore how industry can better engage with people living with multiple sclerosis (PwMS) this MS Awareness Month.
Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers.
In the spirit of Rare Disease Day, which was celebrated on 28 February, we’re looking at the importance of patient engagement in lysosomal storage disorders (LSDs).
Medical publishing is evolving beyond plain language summaries to provide insightful, patient-centred resources to change the course of pharmaceutical research for the better. For patients with rare diseases especially, this could be just what the doctor ordered, writes Olivia Kersey, Patient Engagement Strategist with Prime Patient.
Emma Sutcliffe, SVP Patient Insights and Solutions, Prime Patient shares her reflections about whether the pandemic has helped or hindered patient engagement and research for rare diseases.
We chat with Digital Health Consultant, Barnaby Poulton, about how technology can help amplify the patient voice.
This year’s ISMPP Europe meeting was action packed, with Prime Global sending 5 team members, presenting 5 posters, sharing 7 publication extenders, and moderating 2 roundtables! Here, we share some of our key highlights from the conference.
read more >>
Olivia Kersey, Patient Engagement Strategist, outlines what we can learn from 2021 to optimise patient engagement strategy and implementation in 2022.
While there would be no such thing as the pharmaceutical industry without patients, it’s only in recent years that collaboration with patients has started to enter the mainstream. While 2021 was a good year for patient engagement, 2022 can be both bigger and better.